华海药业：防御性强 积极留意
2009年10月09日08:49
来源：中国证券网·上海证券报 　

　　公司是国内最大的普利类原料药生产企业，也成为国内抗艾滋病药物治疗方案所需的蛋白酶抑制剂、核苷类逆转录酶抑制剂、非核苷类逆转录酶抑制剂三大系列中均有产品获得国家批准生产的唯一企业。
 
近期医药股走势相对强劲，可关注。

Huahai: Defense strong positive note
At 08:49 on October 9, 2009
Source: China Securities Securities News Online Sea

Plymouth is the largest class raw material drug production enterprises has also become a national anti-AIDS drug treatment programs needed to protease inhibitors, nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, three series in both There products have only ratified the production company.
 
Pharmaceutical stocks relative strength of the recent trend may be concerned about.

• 上一篇文章： 艾滋病母婴传播途径